Squarepoint
SGHT icon

Squarepoint’s Sight Sciences SGHT Stock Holding History

Squarepoint’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
218,108
-113,646
-34% -$523K ﹤0.01% 2776
2026
Q1 		$1.25M Buy
331,754
+291,079
+716% +$1.57M ﹤0.01% 2584
2025
Q4 		$323K Buy
+40,675
New +$260K ﹤0.01% 3546
2025
Q2 		– Sell
-166,405
Closed -$399K – 4990
2025
Q1 		$399K Sell
166,405
-2,806
-2% -$7.9K ﹤0.01% 3500
2024
Q4 		$616K Buy
169,211
+128,355
+314% +$585K ﹤0.01% 3542
2024
Q3 		$257K Buy
40,856
+27,697
+210% +$186K ﹤0.01% 3553
2024
Q2 		$87.8K Sell
13,159
-41,809
-76% -$247K ﹤0.01% 3819
2024
Q1 		$290K Sell
54,968
-89,695
-62% -$422K ﹤0.01% 3414
2023
Q4 		$746K Buy
144,663
+24,575
+20% +$75.8K ﹤0.01% 2729
2023
Q3 		$405K Buy
120,088
+90,981
+313% +$598K ﹤0.01% 2946
2023
Q2 		$241K Buy
29,107
+18,029
+163% +$162K ﹤0.01% 3101
2023
Q1 		$96.8K Buy
+11,078
New +$123K ﹤0.01% 2976
2022
Q3 		– Sell
-21,778
Closed -$196K – 3386
2022
Q2 		$196K Buy
+21,778
New +$192K ﹤0.01% 2489

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Squarepoint's SGHT Position: Q2 2026 in Review

Squarepoint reduced its Sight Sciences (SGHT) stake by 34% in Q2 2026, selling an estimated $523K and leaving 218,108 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2776.

Squarepoint first reported a position in SGHT in Q2 2022 and has held it in 13 quarters since. The position peaked at $1.25M in Q1 2026. 111 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Squarepoint held 218,108 shares of Sight Sciences worth $1.18M as of Q2 2026.
  • Squarepoint sold 113,646 Sight Sciences shares in Q2 2026, an estimated $523K.
  • Sight Sciences made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2776 holding.
  • Squarepoint first reported a position in Sight Sciences in Q2 2022 and has held it in 13 quarters since.
  • Squarepoint's Sight Sciences position peaked at $1.25M in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.